Hyderabad-based nutraceutical startup ZeroHarm Sciences has raised ₹65 crore in a Series A round led by Kotak Alternate Asset Managers, with participation from Alkemi Growth Capital. The funds will fuel global expansion, brand building, and R&D scale-up as the company advances its nano-formulated, plant-based preventive healthcare platform.